PURA - Puration Reveals Long-Term Cannabis Market Potential
January 30 2020 - 12:54PM
InvestorsHub NewsWire
PURA - Puration Reveals Long-Term
Cannabis Market Potential
DALLAS, TX -- January 30, 2020 -- InvestorsHub NewsWire --
Puration, Inc. (USOTC:
PURA) management today addressed the overall cannabis market
and the company's plan to succeed in the long-term.
Management acknowledges the lackluster cannabis sector performance
since the 2018 rally in conjunction with the nationwide
legalization of recreational marijuana in Canada. Management
is aware of the analyst reports indicating that cannabis sector
enterprises are running low on investment capital and that sector
performance is hindering the potential to find new
investment. In reaction to overall market conditions PURA
management highlights that PURA's long-term strategy has been to
start small, learn, adapt, expand incrementally and repeat.
Management compares the beverage production issues now facing
Canopy Growth (CGC)
that have resulted in the indefinite delay of their planned
beverage launch to the start small, learn, adapt and expand
incrementally approach that PURA has taken to make its EVERx CBD
Sport Water the leading beverage in its category:
"First mover advantage does not necessarily go hand in hand with
being the biggest mover," said PURA CEO Brian Shibley. "Going
big into a new field means failing big. New enterprises more
times than not face unforeseen problems. After all, you're doing
something new. How could you know what the problems you're
going to face? It might be a production problem. It
might be a market receptivity problem. Invest $1
billion in a new enterprise and you have a $1
billion problem. Invest $100,000 in a new
enterprise and you have
a $100,000 problem. $100,000 problems are
easier to fix then $1 billion problems and I contend that
the knowledge acquired from the $100,000 problem is just
as valuable as the knowledge acquired from the $1
billion problem. I repeat, first-mover advantage does
not necessarily go hand in hand with biggest mover advantage. We
have, for instance, experienced shelf-life problems with the
suspension of CBD in our beverages. We have learned the
market does not like some flavors as much as others. We have
refined our formula and changed the proportion of the flavors we
produced. Among other lessons learned through experience
where we started small, learned, adapted and expanded in small
increments, PURA now has a very valuable body of knowledge.
We also do not suffer large financial liabilities for the lessons
learned from failing small. With the success of our maiden
beverage and our valuable body of cannabis beverage industry
knowledge, we believe PURA is well-positioned to not only sustain
in the long-term but also to seize the prevailing cannabis sector
opportunity to acquire attractively priced cannabis sector
assets."
PURA yesterday announced plans to further pursue the prevailing
cannabis consolidation market opportunity by acquiring smaller
cannabis infusion companies. Multiple cannabis investment
market analysts have forecasted a market wide consolidation as
larger cannabis sector firms acquire smaller firms. PURA has
built expertise and resources to infuse cannabis into beverages and
is now looking to expand the capacity to include food infusion
capacity. PURA is currently exploring the acquisition of
Kali-Extracts' (USOTC:
KALY) CBD confections business. PURA management now
confirms that the company is also exploring additional acquisition
opportunities. PURA currently produces the leading CBD
beverage in the sports nutrition market, EVERx CBD Sports
Water. EVERx now has distribution in Europe, Latin
America and Africa in addition to within the United
States. PURA management believes the company is well staged
for acquiring and growing additional cannabis infused beverages and
foods.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024